High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.

MLA

Duprez, Fréderic, et al. “High-Dose Reirradiation with Intensity-Modulated Radiotherapy for Recurrent Head-and-Neck Cancer: Disease Control, Survival and Toxicity.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 111, no. 3, June 2014, pp. 388–92. EBSCOhost, https://doi.org/10.1016/j.radonc.2014.04.018.

APA

Duprez, F., Berwouts, D., Madani, I., Bonte, K., Boterberg, T., De Gersem, W., Deron, P., Huvenne, W., & De Neve, W. (2014). High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 111(3), 388–392. https://doi.org/10.1016/j.radonc.2014.04.018

Chicago

Duprez, Fréderic, Dieter Berwouts, Indira Madani, Katrien Bonte, Tom Boterberg, Werner De Gersem, Philippe Deron, Wouter Huvenne, and Wilfried De Neve. 2014. “High-Dose Reirradiation with Intensity-Modulated Radiotherapy for Recurrent Head-and-Neck Cancer: Disease Control, Survival and Toxicity.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 111 (3): 388–92. doi:10.1016/j.radonc.2014.04.018.